Drug intelligence / Profile preview

Herbapect

Development stage: Unknown
Lead developer: Aflofarm
Modality: Small Molecules
Administration: Oral

Overview

Herbapect is an herbal combination cough syrup developed and marketed by Aflofarm Farmacja Polska. It contains three active ingredients: thyme herb liquid extract (*Thymus vulgaris* L.), cowslip tincture (*Primula veris* L.), and sulfogaiacol (potassium guaiacolsulfonate). Indicated for the treatment of upper respiratory tract infections, it acts as an expectorant to alleviate persistent dry cough and facilitate the clearing of mucus. The product is an over-the-counter (OTC) medication widely used in Poland and is formulated as a sugar-free syrup suitable for diabetics, although it contains small amounts of ethanol and sorbitol.

Brand names: Herbapect
Other names: Herbapect syrupHerbapect-Aflofarm Farmacja Polska

Beyond the preview

Go deeper on Herbapect.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herbapect.

Explore the full profile